Kubota Pharmaceutical Holdings Co.,Ltd. operates as a holding company. The company, through its subsidiaries, specializes in identifying and developing therapeutics to treat the ophthalmic disorders. Kubota Pharmaceutical Holdings serves customers worldwide.

Consolidated Financial Results For The Nine Months Ended September 30, 2024 (Under Ifrs)

Consolidated Financial Results For The Six Months Ended June 30, 2024 (Under Ifrs)

[Delayed] Consolidated Financial Results For The Three Months Ended March 31, 2024 (Under Ifrs)

Partial Correction: Consolidated Financial Results For The Fiscal Year Ended December 31, 2023 (Under Ifrs)

第25回新株予約権（行使価格修正条項付）の月間行使状況に関するお知らせ

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00